Search Results
Results for: ""
Crinetics Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026
Crinetics will report first quarter 2026 financial results on Thursday, May 7, 2026 after the market closes. Company management will...
READ MORE →Webcast: Crinetics Pharmaceuticals to Report First Quarter 2026 Financial Results
Event Date: May 7, 2026
READ MORE →Crinetics Pharmaceuticals Announces Submission of Marketing Authorization Application in Brazil for Palsonify™ (Paltusotine) in Acromegaly
Crinetics announces the submission of a Marketing Authorization Application (MAA) to Brazil’s National Health Surveillance Agency (ANVISA) for PALSONIFY™ (paltusotine),...
READ MORE →Crinetics to Participate in TD Cowen 46 Annual Health Care Conference
Event Date: March 4, 2026
READ MORE →Webcast: Crinetics to Report Fourth Quarter and Full Year 2025 Financial Results
Crinetics Pharmaceuticals will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026 after the market...
READ MORE →Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Crinetics reports financial results for the fourth quarter and full year 2025. Company management will hold a live conference call...
READ MORE →Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences in March
Crinetics announced that company management will participate in two upcoming investor conferences: the TD Cowen 46th Annual Health Care Conference...
READ MORE →Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
Crinetics announced that it will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026 after...
READ MORE →Crinetics Initiates Phase 2/3 Pediatric Trial Evaluating Atumelnant in Congenital Adrenal Hyperplasia (CAH)
Crinetics announced that the first patient has been dosed in the BALANCE-CAH Phase 2/3 trial evaluating investigational candidate atumelnant, a...
READ MORE →Webcast: Crinetics Pharmaceuticals Presentation at the 44th Annual J.P. Morgan Healthcare Conference
Scott Struthers, Ph.D., Founder and Chief Executive Officer of Crinetics, will present at the 44th Annual J.P. Morgan Healthcare Conference being...
READ MORE →Please click CONTINUE below to learn more about a new treatment option. This website contains information about a prescription medicine.
